OptionsHouse

Options Trading News

October 7, 2011  Fri 12:20 PM CT

CELG: SEE CHART GET CHAIN FIND STRATEGIES
Shares of Celgene are near multi-year highs, but option traders apparently believe that resistance levels will hold.

CELG trades at 63.11, down 0.4 percent. The biopharmaceutical company's stock hit a 52-week high of $65.86 on Sept. 20, which is resistance going back for at least three years. Shares have been on the rise since plunging to support at $52 in early August.

More than 5,000 November 65 calls were sold today against open interest of 1,259 contracts, according to optionMONSTER's systems. The largest block of 3,127 went for the bid price of $2.15.

We have seen a considerable amount of call selling in institutional size the last two days. It appears that traders are trying to capture high volatility premiums but don't see equities continuing the current rally.
Share this article with your friends


Related Stories

CELG

Short-term bulls betting on Celgene

February 20, 2015

The drug maker gapped higher at the open after the European Commission approved wider use of the company's Revlimid myeloma treatment.

Invest Like a Monster - Las Vegas: March 13-14

Premium Services

Webinar Recording

Turbo Charge Your Trading Profits

Education & Strategy

The Strike-Based Greeks

The other Greeks (Gamma, Vega, and Theta) are calculated by using month and strike data, and not by individual option. These are called strike-based Greeks. Gamma, Theta, and Vega are all strike-based Greeks

View more education articles »